Naftzger J. Christopher
SEC CIK 1496194 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | GC, CCO | 140.5K | — | $37.2K | 3 | 2024-02-01 | 2025-02-14 |
Most active insiders at ABUS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Nguyen Tuan | CFO | — | — |
| 2 | Androski Lindsay | Pres, CEO, Dir | — | — |
| 3 | Sawhney Roger | Dir | — | — |
| 4 | Beardsley Robert A | Dir | — | — |
Naftzger J. Christopher made no open-market trades at ABUS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-19 | 2025-02-14 | ABUS | Arbutus Biopharma Corp | Naftzger J. Christopher | GC, CCO | A - Grant | $0.00 | +54.3K | 140.5K | +63% | $0 |
| 2025-02-05 | 2025-02-04 | ABUS | Arbutus Biopharma Corp | Naftzger J. Christopher | GC, CCO | S - Sale | $3.28 | -11.3K | 86.2K | -12% | -$37.2K | |
| D | 2024-02-05 | 2024-02-01 | ABUS | Arbutus Biopharma Corp | Naftzger J. Christopher | GC, CCO | A - Grant | $0.00 | +95.1K | 95.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations